379 related articles for article (PubMed ID: 30391801)
1. Enhancement of antitumor potency of extracellular vesicles derived from natural killer cells by IL-15 priming.
Zhu L; Kalimuthu S; Oh JM; Gangadaran P; Baek SH; Jeong SY; Lee SW; Lee J; Ahn BC
Biomaterials; 2019 Jan; 190-191():38-50. PubMed ID: 30391801
[TBL] [Abstract][Full Text] [Related]
2. Targeting and Therapy of Glioblastoma in a Mouse Model Using Exosomes Derived From Natural Killer Cells.
Zhu L; Oh JM; Gangadaran P; Kalimuthu S; Baek SH; Jeong SY; Lee SW; Lee J; Ahn BC
Front Immunol; 2018; 9():824. PubMed ID: 29740437
[TBL] [Abstract][Full Text] [Related]
3. Exosomes Derived From Natural Killer Cells Exert Therapeutic Effect in Melanoma.
Zhu L; Kalimuthu S; Gangadaran P; Oh JM; Lee HW; Baek SH; Jeong SY; Lee SW; Lee J; Ahn BC
Theranostics; 2017; 7(10):2732-2745. PubMed ID: 28819459
[No Abstract] [Full Text] [Related]
4. Novel alternatives to extracellular vesicle-based immunotherapy - exosome mimetics derived from natural killer cells.
Zhu L; Gangadaran P; Kalimuthu S; Oh JM; Baek SH; Jeong SY; Lee SW; Lee J; Ahn BC
Artif Cells Nanomed Biotechnol; 2018; 46(sup3):S166-S179. PubMed ID: 30092165
[TBL] [Abstract][Full Text] [Related]
5. Comparison of characteristics and tumor targeting properties of extracellular vesicles derived from primary NK cells or NK-cell lines stimulated with IL-15 or IL-12/15/18.
Aarsund M; Segers FM; Wu Y; Inngjerdingen M
Cancer Immunol Immunother; 2022 Sep; 71(9):2227-2238. PubMed ID: 35119498
[TBL] [Abstract][Full Text] [Related]
6. Proteome Analysis of Human Natural Killer Cell Derived Extracellular Vesicles for Identification of Anticancer Effectors.
Choi JW; Lim S; Kang JH; Hwang SH; Hwang KC; Kim SW; Lee S
Molecules; 2020 Nov; 25(21):. PubMed ID: 33182448
[TBL] [Abstract][Full Text] [Related]
7. Recombinant human prolactin improves antitumor effects of murine natural killer cells in vitro and in vivo.
Sun R; Wei H; Zhang J; Li A; Zhang W; Tian Z
Neuroimmunomodulation; 2002-2003; 10(3):169-76. PubMed ID: 12481157
[TBL] [Abstract][Full Text] [Related]
8. Cancer Immunotherapy Based on Natural Killer Cells: Current Progress and New Opportunities.
Hu W; Wang G; Huang D; Sui M; Xu Y
Front Immunol; 2019; 10():1205. PubMed ID: 31214177
[TBL] [Abstract][Full Text] [Related]
9. High levels of circulating extracellular vesicles with altered expression and function during pregnancy.
Nardi Fda S; Michelon TF; Neumann J; Manvailer LF; Wagner B; Horn PA; Bicalho Mda G; Rebmann V
Immunobiology; 2016 Jul; 221(7):753-60. PubMed ID: 27005781
[TBL] [Abstract][Full Text] [Related]
10. Natural Killer Cell-Derived Extracellular Vesicles: Novel Players in Cancer Immunotherapy.
Wu F; Xie M; Hun M; She Z; Li C; Luo S; Chen X; Wan W; Wen C; Tian J
Front Immunol; 2021; 12():658698. PubMed ID: 34093547
[TBL] [Abstract][Full Text] [Related]
11. Natural killer cell-based adoptive immunotherapy eradicates and drives differentiation of chemoresistant bladder cancer stem-like cells.
Ferreira-Teixeira M; Paiva-Oliveira D; Parada B; Alves V; Sousa V; Chijioke O; Münz C; Reis F; Rodrigues-Santos P; Gomes C
BMC Med; 2016 Oct; 14(1):163. PubMed ID: 27769244
[TBL] [Abstract][Full Text] [Related]
12. hIL-15-gene modified human natural killer cells (NKL-IL15) exhibit anti-human leukemia functions.
Jiang W; Zhang C; Tian Z; Zhang J
J Cancer Res Clin Oncol; 2018 Jul; 144(7):1279-1288. PubMed ID: 29737430
[TBL] [Abstract][Full Text] [Related]
13. Isolation of a cytolytic subpopulation of extracellular vesicles derived from NK cells containing NKG7 and cytolytic proteins.
Aarsund M; Nyman TA; Stensland ME; Wu Y; Inngjerdingen M
Front Immunol; 2022; 13():977353. PubMed ID: 36189227
[TBL] [Abstract][Full Text] [Related]
14. Natural Killer Cell-Derived Vesicular miRNAs: A New Anticancer Approach?
Fabbri M
Cancer Res; 2020 Jan; 80(1):17-22. PubMed ID: 31672842
[TBL] [Abstract][Full Text] [Related]
15. Extracellular Vesicles from
Luo ZW; Xia K; Liu YW; Liu JH; Rao SS; Hu XK; Chen CY; Xu R; Wang ZX; Xie H
Int J Nanomedicine; 2021; 16():2949-2963. PubMed ID: 33907401
[TBL] [Abstract][Full Text] [Related]
16. Real-Time Tracking of
Uong TNT; Lee KH; Ahn SJ; Kim KW; Min JJ; Hyun H; Yoon MS
Front Immunol; 2018; 9():825. PubMed ID: 29770131
[TBL] [Abstract][Full Text] [Related]
17. Cytokine-enhanced cytolytic activity of exosomes from NK Cells.
Enomoto Y; Li P; Jenkins LM; Anastasakis D; Lyons GC; Hafner M; Leonard WJ
Cancer Gene Ther; 2022 Jun; 29(6):734-749. PubMed ID: 34316033
[TBL] [Abstract][Full Text] [Related]
18. Professional killers: The role of extracellular vesicles in the reciprocal interactions between natural killer, CD8+ cytotoxic T-cells and tumour cells.
Del Vecchio F; Martinez-Rodriguez V; Schukking M; Cocks A; Broseghini E; Fabbri M
J Extracell Vesicles; 2021 Apr; 10(6):e12075. PubMed ID: 33815694
[TBL] [Abstract][Full Text] [Related]
19. Combined immunogene therapy of IL-6 and IL-15 enhances anti-tumor activity through augmented NK cytotoxicity.
Lin CY; Chuang TF; Liao KW; Huang YJ; Pai CC; Chu RM
Cancer Lett; 2008 Dec; 272(2):285-95. PubMed ID: 18760876
[TBL] [Abstract][Full Text] [Related]
20. Natural killer cell-derived extracellular vesicles in cancer therapy.
Farcas M; Inngjerdingen M
Scand J Immunol; 2020 Oct; 92(4):e12938. PubMed ID: 32697853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
